Indegene Stock Gets Fresh Buy Call; Motilal Oswal Turns Bullish On Pharma Outsourcing Tailwinds — Check Target Price

As reported by NDTV Profit - Latest

Operationally, Indegene remains in the top quartile, given superior revenue per employee, higher than IT services peers and 3x more than the healthcare BPO peers, says Motilal Oswal.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

INDIAN Indian 10-year bond hits 4-month low on US debt rout Markets-Economic Times
INDIAN Integrum Energy Infrastructure files papers with Sebi to raise funds via IPO Markets-Economic Times
INDIAN UK consumer confidence hits over two-year high in September as personal finances improve: GfK Markets-Economic Times
INDIAN Rain collaborates with BioBTX for renewable aromatic products Share Market Today
INDIAN Acevector IPO: Analysts assign 'avoid' tag amid stiff competition, losses Share Market Today
INDIAN Time for India to reconsider self-listing of exchanges, says NSE chairman Share Market Today
INDIAN Vascon Engineers gains on securing work contract worth Rs 661 crore from Qualcomm India Share Market Today
INDIAN Hormuz reopening hope to support silver, resistance at $65: Mirae Asset Share Market Today

Indegene Stock Gets Fresh Buy Call; Motilal Oswal Turns Bullish On Pharma Outsourcing Tailwinds — Check Target Price

More from Market Samachar